Cassava Intervention Project

Sponsor
Ministry of Public Health, Democratic Republic of the Congo (Other)
Overall Status
Completed
CT.gov ID
NCT03157336
Collaborator
National Institutes of Health (NIH) (NIH), Oregon Health and Science University (Other), Michigan State University (Other), University of Kinshasa (Other), National Institute of Environmental Health Sciences (NIEHS) (NIH)
1,200
1
2
58.1
20.7

Study Details

Study Description

Brief Summary

Investigators will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (women training other women in the WTM) with that by community-health worker specialists.

Condition or Disease Intervention/Treatment Phase
  • Other: Non Inferiority WTM Interventional Trial
N/A

Detailed Description

The proposed project seeks methods to prevent and elucidate biomarkers of neurocognition and motor deficits associated with chronic dietary reliance on cyanogenic cassava, a staple food crop for more than 600 millions of people living in the tropics. Aim 1 will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (women training other women in the WTM) with that by community-health worker specialists (2 intervention training arms). Aim 2 will determine whether post-intervention reductions in cassava cyanogenic content and child U-SCN are associated with changes in biomarkers of cassava neurotoxicity particularly 8,12-iso-iPF2α-VI isoprostane (oxidant marker), carbamoylated albumin fragments KVPQVSTPTLVEVSR (residues 438-452) and LDELRDEGKASSAK (residues 206-219), or homocitrulline (carbamoylating markers), and scores at the KABC-II cognition and BOT-2 motor testing.

Study Design

Study Type:
Interventional
Actual Enrollment :
1200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
We will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (Arm 1 = women training other women in the WTM) with that by community-health worker specialists (Arm 2= specialist led intervention arm)We will implement a novel cassava processing method (wetting method, WTM) that safely removes cyanogenic compounds from cassava flour prior to human consumption in a stratified village-cluster randomized non-inferiority trial so as to compare the effectiveness of a peer-led intervention (Arm 1 = women training other women in the WTM) with that by community-health worker specialists (Arm 2= specialist led intervention arm)
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Toxicodietary and Genetic Determinants of Susceptibility to Neurodegeneration
Actual Study Start Date :
Jul 30, 2017
Actual Primary Completion Date :
Jun 1, 2022
Actual Study Completion Date :
Jun 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Peer-led Intervention

Peers (community women in leading roles) training other women in the wetting method for safe processing of cassava in a non-inferiority intervention trial.

Other: Non Inferiority WTM Interventional Trial
The intervention will implement the WTM cassava processing technique in participating households. Twenty women (in leading roles) will be our principal candidates to serve as peer trainers. Together with a 20 community health worker specialists, these women will be trained in the WTM technique by the Kinshasa team of community health workers who are experts in the WTM method. Those who master the technique will then be certified as trainers to train and support other small groups of other mothers throughout a two-year period in the implementation of the WTM for the safer processing of food for their families. Both the community health worker specialists and trained women (prospective trainers) would have to be able to bring the cassava cyanogenic content to the lowest achievable level, which must be < 10 ppm as per the recommendations of the World Health Organization.

Experimental: Specialist-led Intervention

Specialists (nutritionists) training other women in the wetting method for safe processing of cassava in a non-inferiority intervention trial..

Other: Non Inferiority WTM Interventional Trial
The intervention will implement the WTM cassava processing technique in participating households. Twenty women (in leading roles) will be our principal candidates to serve as peer trainers. Together with a 20 community health worker specialists, these women will be trained in the WTM technique by the Kinshasa team of community health workers who are experts in the WTM method. Those who master the technique will then be certified as trainers to train and support other small groups of other mothers throughout a two-year period in the implementation of the WTM for the safer processing of food for their families. Both the community health worker specialists and trained women (prospective trainers) would have to be able to bring the cassava cyanogenic content to the lowest achievable level, which must be < 10 ppm as per the recommendations of the World Health Organization.

Outcome Measures

Primary Outcome Measures

  1. Change in food cyanogenic exposure [From baseline to 6-month time points]

    Cassava cyanogenic content

  2. Change in internal cyanogenic exposure [From baseline to 6-month time points]

    Urinary concentrations of thiocyanate (U-SCN)

  3. Change in oxidation damage [From baseline to 6-month time points]

    Serum isoprostanes

  4. Change in carbamoylation [From baseline to 6-month time points]

    serum albumin peptidic carbamoylation

  5. Change in carbamoylation surrogate [From baseline to 6-month time points]

    serum homocitrulline

Secondary Outcome Measures

  1. Change in cognition performance [From baseline to 6-month time points]

    Kaufman Assessment Battery for Children (KABC-II) for cognition testing score

  2. Change in motor proficiency [From baseline to 6-month time points]

    Motor proficiency Bruininks/Oseretsky Testing (BOT-2) score

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Households with a konzo child and non-konzo sibling between 5 and 12 years

  • Presence of a biological mother primarily responsible for the household food preparation and caring for the children

  • Mother consenting to participate in this study

Exclusion Criteria:
  • History of seizures

  • History of cerebral malaria

  • History of retroviral (HIV-HTLV) infections

Contacts and Locations

Locations

Site City State Country Postal Code
1 INRB Kinshasa Congo, The Democratic Republic of the

Sponsors and Collaborators

  • Ministry of Public Health, Democratic Republic of the Congo
  • National Institutes of Health (NIH)
  • Oregon Health and Science University
  • Michigan State University
  • University of Kinshasa
  • National Institute of Environmental Health Sciences (NIEHS)

Investigators

  • Study Director: Mumba Ngoyi, Ministry of Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Desire Tshala-Katumbay, Head Complex Morbidity Unit, Ministry of Public Health, Democratic Republic of the Congo
ClinicalTrials.gov Identifier:
NCT03157336
Other Study ID Numbers:
  • FWA00017202
  • R01ES019841
First Posted:
May 17, 2017
Last Update Posted:
Jun 6, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Desire Tshala-Katumbay, Head Complex Morbidity Unit, Ministry of Public Health, Democratic Republic of the Congo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 6, 2022